CME Group Inc. $CME Shares Acquired by Keybank National Association OH

Keybank National Association OH lifted its stake in shares of CME Group Inc. (NASDAQ:CME) by 15.4% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 153,625 shares of the financial services provider’s stock after purchasing an additional 20,477 shares during the period. Keybank National Association OH’s holdings in CME Group were worth $41,508,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CME. Amundi grew its position in CME Group by 24.0% in the 2nd quarter. Amundi now owns 1,987,347 shares of the financial services provider’s stock valued at $548,150,000 after buying an additional 385,225 shares in the last quarter. Alley Investment Management Company LLC lifted its stake in shares of CME Group by 86.0% in the 3rd quarter. Alley Investment Management Company LLC now owns 29,223 shares of the financial services provider’s stock worth $7,896,000 after acquiring an additional 13,512 shares during the period. Elevate Capital Advisors LLC boosted its holdings in shares of CME Group by 85.2% in the third quarter. Elevate Capital Advisors LLC now owns 8,519 shares of the financial services provider’s stock valued at $2,302,000 after acquiring an additional 3,919 shares in the last quarter. Victory Financial Group LLC boosted its holdings in shares of CME Group by 310.2% in the second quarter. Victory Financial Group LLC now owns 3,044 shares of the financial services provider’s stock valued at $839,000 after acquiring an additional 2,302 shares in the last quarter. Finally, Chicago Capital LLC increased its stake in shares of CME Group by 583.8% during the third quarter. Chicago Capital LLC now owns 13,327 shares of the financial services provider’s stock valued at $3,601,000 after acquiring an additional 11,378 shares during the period. 87.75% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, Director William R. Shepard acquired 251 shares of the firm’s stock in a transaction that occurred on Tuesday, December 30th. The stock was purchased at an average price of $278.37 per share, with a total value of $69,870.87. Following the purchase, the director owned 258,710 shares of the company’s stock, valued at approximately $72,017,102.70. This trade represents a 0.10% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Terrence A. Duffy sold 25,000 shares of CME Group stock in a transaction that occurred on Thursday, December 11th. The stock was sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the transaction, the chief executive officer owned 65,804 shares in the company, valued at approximately $17,737,468.20. The trade was a 27.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.30% of the company’s stock.

CME Group Trading Down 0.3%

Shares of NASDAQ CME opened at $289.06 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 12 month low of $233.66 and a 12 month high of $291.76. The company has a market cap of $104.24 billion, a price-to-earnings ratio of 28.01, a P/E/G ratio of 3.26 and a beta of 0.27. The business has a fifty day simple moving average of $275.25 and a 200-day simple moving average of $272.35.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th were issued a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.7%. The ex-dividend date was Friday, December 12th. CME Group’s dividend payout ratio (DPR) is presently 48.45%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on CME shares. Raymond James Financial upped their target price on CME Group from $307.00 to $311.00 and gave the stock an “outperform” rating in a research report on Monday, January 5th. JPMorgan Chase & Co. upped their price objective on CME Group from $256.00 to $262.00 and gave the company an “underweight” rating in a report on Thursday, January 22nd. Jefferies Financial Group lowered their target price on CME Group from $304.00 to $302.00 and set a “buy” rating on the stock in a report on Monday, January 12th. Bank of America boosted their price target on shares of CME Group from $201.00 to $209.00 in a research report on Wednesday, December 10th. Finally, Piper Sandler raised their price objective on shares of CME Group from $296.00 to $313.00 and gave the company an “overweight” rating in a research report on Thursday, November 13th. Nine research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $292.18.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.